Monthly
US$200
Billed every month
Sign in to subscribePeramivir Injection
As of 13 November 2026, for Peramivir Injection, 7 applications are listed as under review at China's CDE; 3 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 39 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders39View records ↓
Under-review filings7View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers42View records ↓
API companies with A status12View records ↓
Chemical-drug catalogue
Loaded records: 39 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 39 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | Chengdu Bai Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20266260 | 2026/10/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20264902 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Kang Ji Er Pharma Co., Ltd. romanized | Zhejiang Kang Ji Er Pharma Co., Ltd. romanized | 国药准字H20255783 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yunnan Xian Shi Pharma Co., Ltd. romanized | Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20258166 | 2025/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Cheng Yi Pharma Co., Ltd. romanized | Zhejiang Cheng Yi Pharma Co., Ltd. romanized | 国药准字H20255068 | 2025/07/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20254354 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shi Yao Yin Hu Pharmaceutical Co., Ltd. romanized | Shi Yao Yin Hu Pharmaceutical Co., Ltd. romanized | 国药准字H20253945 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Qidu Pharmaceutical Co., Ltd. | Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20253769 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanized | Shanghai Hua Yuan Anhui Jin Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20253603 | 2025/03/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20253095 | 2025/01/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Yang He Pharmaceuticals Technology Co., Ltd. romanized | Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20249584 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hubei Min Kang Pharma Group Co., Ltd. romanized | Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20249474 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized | Hainan Ai Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20249386 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20249216 | 2024/10/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongguo Da Zhong Pharmaceutical Co., Ltd. romanized | Zhongguo Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20244971 | 2024/09/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20244617 | 2024/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244196 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | 国药准字H20244197 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20244150 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Lang Tian Pharma (Hubei) Co., Ltd. romanized | Lang Tian Pharma (Hubei) Co., Ltd. romanized | 国药准字H20244152 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xian Jing Xi Shuang He Pharma Co., Ltd. romanized | Xian Jing Shuang He Yao Co., Ltd. romanized | 国药准字H20244153 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Zhejiang Guo Jing Pharma Co., Ltd. romanized | 国药准字H20244037 | 2024/06/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H20243910 | 2024/06/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20243908 | 2024/06/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wen Zhou Hai He Pharma Co., Ltd. romanized | Zhejiang Pharmaceuticals Co., Ltd. Xin Chang Pharmaceutical Factory romanized | 国药准字H20243853 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qinghai Chen Fei Pharmaceutical Co., Ltd. romanized | Qinghai Chen Fei Pharmaceutical Co., Ltd. romanized | 国药准字H20243854 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20243856 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243671 | 2024/05/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20243670 | 2024/05/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243672 | 2024/05/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | 2024/04/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243586 | 2024/04/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243215 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20243230 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Ai Mei Jin Pharmaceutical Co., Ltd. romanized | Jiangsu Di Sai Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20243128 | 2024/01/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20243076 | 2024/01/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234725 | 2023/12/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20234693 | 2023/12/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233886 | 2023/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20233789 | 2023/06/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Bai Yu Pharmaceutical Co., Ltd. romanized | Chengdu Bai Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20233678 | 2023/06/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yunnan Xian Shi Pharma Co., Ltd. romanized | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20233672 | 2023/06/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yang Zi Jiang Pharma Group Sichuan Hai Rong Pharma Co., Ltd. romanized | Yang Zi Jiang Pharma Group Sichuan Hai Rong Pharma Co., Ltd. romanized | 国药准字H20233617 | 2023/05/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Zhong Run Drug Research and Development Co., Ltd. romanized | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20233372 | 2023/03/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 42 distinct approval numbers and 36 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20234693 | See source | Category B | XJ05AHP148B002010100475 | NHSA |
| Zhongguo Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20244971 | See source | Category B | XJ05AHP148B002010100967 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243128 | See source | Category B | XJ05AHP148B002010101495 | NHSA |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243215 | See source | Category B | XJ05AHP148B002010101504 | NHSA |
| Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233886 | See source | Category B | XJ05AHP148B002010101749 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20243856 | See source | Category B | XJ05AHP148B002010102087 | NHSA |
| Yang Zi Jiang Pharma Group Sichuan Hai Rong Pharma Co., Ltd. romanized | 国药准字H20233617 | See source | Category B | XJ05AHP148B002010102313 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20249216 | See source | Category B | XJ05AHP148B002010102357 | NHSA |
| Xian Jing Xi Shuang He Pharma Co., Ltd. romanized | 国药准字H20244153 | See source | Category B | XJ05AHP148B002010102492 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243586 | See source | Category B | XJ05AHP148B002010102662 | NHSA |
| Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20243670 | See source | Category B | XJ05AHP148B002010102777 | NHSA |
| Shi Yao Yin Hu Pharmaceutical Co., Ltd. romanized | 国药准字H20253945 | See source | Category B | XJ05AHP148B002010102964 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243671 | See source | Category B | XJ05AHP148B002010103205 | NHSA |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20254354 | See source | Category B | XJ05AHP148B002010103257 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234725 | See source | Category B | XJ05AHP148B002010103492 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20253769 | See source | Category B | XJ05AHP148B002010104145 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20244037 | See source | Category B | XJ05AHP148B002010104187 | NHSA |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20243908 | See source | Category B | XJ05AHP148B002010104251 | NHSA |
| Zhejiang Pharmaceuticals Co., Ltd. Xin Chang Pharmaceutical Factory romanized | 国药准字H20243853 | See source | Category B | XJ05AHP148B002010104586 | NHSA |
| Zhejiang Cheng Yi Pharma Co., Ltd. romanized | 国药准字H20255068 | See source | Category B | XJ05AHP148B002010104615 | NHSA |
| Zhejiang Kang Ji Er Pharma Co., Ltd. romanized | 国药准字H20255783 | See source | Category B | XJ05AHP148B002010104745 | NHSA |
| Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized | 国药准字H20249386 | See source | Category B | XJ05AHP148B002010105775 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20243230 | See source | Category B | XJ05AHP148B002010105789 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20243076 | See source | Category B | XJ05AHP148B002010105821 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20233789 | See source | Category B | XJ05AHP148B002010105847 | NHSA |
| Qinghai Chen Fei Pharmaceutical Co., Ltd. romanized | 国药准字H20243854 | See source | Category B | XJ05AHP148B002010106474 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20233678 | See source | Category B | XJ05AHP148B002010106725 | NHSA |
| Lang Tian Pharma (Hubei) Co., Ltd. romanized | 国药准字H20244152 | See source | Category B | XJ05AHP148B002010109592 | NHSA |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244197 | See source | Category B | XJ05AHP148B002010181917 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20233372 | See source | Category B | XJ05AHP148B002010181979 | NHSA |
| Shanxi Yang He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249584 | See source | Category B | XJ05AHP148B002010183547 | NHSA |
| Yunnan Xian Shi Pharma Co., Ltd. romanized | 国药准字H20258166 | See source | Category B | XJ05AHP148B002010183585 | NHSA |
| Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253095 | See source | Category B | XJ05AHP148B002010183864 | NHSA |
| Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20244150 | See source | Category B | XJ05AHP148B002010183916 | NHSA |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264902 | See source | Category B | XJ05AHP148B002010184183 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20249474 | See source | Category B | XJ05AHP148B002010184564 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243128 | See source | Category B | XJ05AHP148B002010201495 | NHSA |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243215 | See source | Category B | XJ05AHP148B002010201504 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20243856 | See source | Category B | XJ05AHP148B002010202087 | NHSA |
| Yang Zi Jiang Pharma Group Sichuan Hai Rong Pharma Co., Ltd. romanized | 国药准字H20233617 | See source | Category B | XJ05AHP148B002010202313 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20249216 | See source | Category B | XJ05AHP148B002010202357 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243586 | See source | Category B | XJ05AHP148B002010202662 | NHSA |
| Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20243670 | See source | Category B | XJ05AHP148B002010202777 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243671 | See source | Category B | XJ05AHP148B002010203205 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234725 | See source | Category B | XJ05AHP148B002010203492 | NHSA |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20243908 | See source | Category B | XJ05AHP148B002010204251 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20244617 | See source | Category B | XJ05AHP148B002010204451 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20243230 | See source | Category B | XJ05AHP148B002010205789 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20243076 | See source | Category B | XJ05AHP148B002010205821 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20233789 | See source | Category B | XJ05AHP148B002010205847 | NHSA |
| Qinghai Chen Fei Pharmaceutical Co., Ltd. romanized | 国药准字H20243854 | See source | Category B | XJ05AHP148B002010206474 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20233678 | See source | Category B | XJ05AHP148B002010206725 | NHSA |
| Lang Tian Pharma (Hubei) Co., Ltd. romanized | 国药准字H20244152 | See source | Category B | XJ05AHP148B002010209592 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20233372 | See source | Category B | XJ05AHP148B002010281979 | NHSA |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243215 | See source | Category B | XJ05AHP148B002010301504 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20243856 | See source | Category B | XJ05AHP148B002010302087 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20249216 | See source | Category B | XJ05AHP148B002010302357 | NHSA |
| Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20243670 | See source | Category B | XJ05AHP148B002010302777 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234725 | See source | Category B | XJ05AHP148B002010303492 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20244617 | See source | Category B | XJ05AHP148B002010304451 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20243076 | See source | Category B | XJ05AHP148B002010305821 | NHSA |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243215 | See source | Category B | XJ05AHP148B002010401504 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234725 | See source | Category B | XJ05AHP148B002010403492 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20243076 | See source | Category B | XJ05AHP148B002010405821 | NHSA |
| Jiangsu Wu Zhong Pharmaceuticals Group Co., Ltd. Suzhou Pharmaceutical Factory romanized | 国药准字H20243910 | See source | Category B | XJ05AHP148B002020101504 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020102662 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243672 | See source | Category B | XJ05AHP148B002020103205 | NHSA |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244196 | See source | Category B | XJ05AHP148B002020181917 | NHSA |
| Yunnan Xian Shi Pharma Co., Ltd. romanized | 国药准字H20233672 | See source | Category B | XJ05AHP148B002020181979 | NHSA |
| Shanxi Yang He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20249584 | See source | Category B | XJ05AHP148B002020183547 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020202662 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243672 | See source | Category B | XJ05AHP148B002020203205 | NHSA |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244196 | See source | Category B | XJ05AHP148B002020281917 | NHSA |
| Yunnan Xian Shi Pharma Co., Ltd. romanized | 国药准字H20233672 | See source | Category B | XJ05AHP148B002020281979 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020302662 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020402662 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020502662 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020602662 | NHSA |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243585 | See source | Category B | XJ05AHP148B002020702662 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 7 filings and 7 distinct first applicants.
Generic 6 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Zhang Lian Du Lei Pharmaceutical Co., Ltd. romanized | CYHS2602403 | Generic | 2026/09/24 | Not stated by source | CDE |
| Hebei Tian Cheng Pharma Co., Ltd. romanized | CYHB2601809 | Supplement | 2026/09/23 | Not stated by source | CDE |
| CISEN PHARMACEUTICAL CO., LTD. | CYHS2601554 | Generic | 2026/07/01 | Not stated by source | CDE |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized; Fu Ren Pharma Group Co., Ltd. romanized | CYHS2600509 | Generic | 2026/02/25 | Not stated by source | CDE |
| HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CYHS2502916 | Generic | 2025/08/12 | Not stated by source | CDE |
| Hainan Hui Pu Sen Pharmaceuticals Bio Technology Co., Ltd. romanized | CYHS2502187 | Generic | 2025/06/18 | Not stated by source | CDE |
| Shandong Fang Ming Pharma Group Co., Ltd. romanized | CYHS2502112 | Generic | 2025/06/12 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Zhang Lian Du Lei Pharmaceutical Co., Ltd. romanized | CYHS2602403 | Generic | 2026/09/24 | Not stated by source | CDE |
| CISEN PHARMACEUTICAL CO., LTD. | CYHS2601554 | Generic | 2026/07/01 | Not stated by source | CDE |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized; Fu Ren Pharma Group Co., Ltd. romanized | CYHS2600509 | Generic | 2026/02/25 | Not stated by source | CDE |
API registrations
Non-component matches: 12 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 帕拉米韦 · No verified English name | Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | Y20250001299 | I | Exact ingredient | 2025/12/09 | CDE |
| 帕拉米韦 · No verified English name | Chongqing Lang Tian Pharmaceutical Co., Ltd. romanized | Y20250001029 | I | Exact ingredient | 2025/10/10 | CDE |
| 帕拉米韦 · No verified English name | Beng Bu Feng Yuan Tu Shan Pharmaceutical Co., Ltd. romanized | Y20240001310 | A | Exact ingredient | 2026/08/07 | CDE |
| 帕拉米韦 · No verified English name | Zhi En Bio Technology Co., Ltd. romanized | Y20230001127 | A | Exact ingredient | 2026/08/22 | CDE |
| 帕拉米韦 · No verified English name | Han Rui Pharma (Jing Men) Co., Ltd. romanized | Y20220001317 | A | Exact ingredient | 2026/05/06 | CDE |
| 帕拉米韦 · No verified English name | Hangzhou Fu Si Te Pharma Co., Ltd. romanized | Y20220000643 | A | Exact ingredient | 2024/04/08 | CDE |
| 帕拉米韦 · No verified English name | Hebei Tian Cheng Pharma Co., Ltd. romanized | Y20220000572 | A | Exact ingredient | 2026/09/22 | CDE |
| 帕拉米韦 · No verified English name | Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | Y20220000324 | A | Exact ingredient | 2025/07/24 | CDE |
| 帕拉米韦 · No verified English name | Chongqing Bo Teng Pharmaceutical Technology Co., Ltd. romanized | Y20220000488 | A | Exact ingredient | 2024/03/25 | CDE |
| 帕拉米韦 · No verified English name | Hubei Si Huan Pharmaceutical Co., Ltd. romanized | Y20210001292 | A | Exact ingredient | 2023/10/09 | CDE |
| 帕拉米韦 · No verified English name | Tianjin Tai Pu Pharmaceutical Co., Ltd. romanized | Y20210001138 | A | Exact ingredient | 2023/06/07 | CDE |
| 帕拉米韦 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20210000127 | A | Exact ingredient | 2025/05/21 | CDE |
| 帕拉米韦 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20200001197 | A | Exact ingredient | 2024/12/13 | CDE |
| 帕拉米韦 · No verified English name | Hunan Kai Bo Bio Pharma Co., Ltd. romanized | Y20190009834 | A | Exact ingredient | 2023/03/24 | CDE |
| 帕拉米韦 · No verified English name | Hunan Kai Bo Bio Pharma Co., Ltd. romanized | Y20190000298 | I | Exact ingredient | 2019/04/29 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/03Marketing application approved
Shandong Yi Kang Pharma Co., Ltd. romanized
CYHS2502356 · 国药准字H20266521
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 89 ↗ -
2026/09/24Accepted
Hubei Zhang Lian Du Lei Pharmaceutical Co., Ltd. romanized
CYHS2602403
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ -
2026/09/23Accepted
Hebei Tian Cheng Pharma Co., Ltd. romanized
CYHB2601809
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Peramivir Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy